Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
Recruiting · NCT07172204 · Registry updated 2026-02-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-02-04 | NCT07172204 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
| First Affiliated Hospital of Zhejiang University | 201 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Chao-Yang Hospital, Capital Medical University | Beijing | China | 10 |
| Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou | China | 1 |
| Shenzhen University General Hospital | Shenzhen | China | 5 |
| The First Affiliated Hospital of Soochow University | Suzhou | China | 42 |
| The Second Affiliated Hospital of Nanchang University | Nanchang | China | 32 |